Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening.
High mobility group box 1 (HMGB1), a highly conserved, ubiquitous protein, is released into the circulation during sterile inflammation (e.g. arthritis, trauma) and circulatory shock. It participates in the pathogenesis of delayed inflammatory responses and organ dysfunction. While several molecules...
Main Authors: | Domokos Gerö, Petra Szoleczky, Katalin Módis, John P Pribis, Yousef Al-Abed, Huan Yang, Sangeeta Chevan, Timothy R Billiar, Kevin J Tracey, Csaba Szabo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3682954?pdf=render |
Similar Items
-
Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial Cells.
by: Domokos Gerö, et al.
Published: (2016-01-01) -
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01) -
Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14
by: Sodam Kim, et al.
Published: (2013-03-01) -
Redox modifications of cysteine residues regulate the cytokine activity of HMGB1
by: Huan Yang, et al.
Published: (2021-06-01) -
Sequestering HMGB1 via DNA-conjugated beads ameliorates murine colitis.
by: Zhongliang Ju, et al.
Published: (2014-01-01)